xCures has partnered with a new oncology company specializing in a metabolic approach to cancer treatment. Their PROMAP study is testing a special diet designed to improve responses to standard-of-care chemotherapy in pancreatic cancer.
Research Partners
POETIC
xCures collaborates with POETIC, a non-profit organization that manages pediatric oncology early phase trials, to get children, adolescents, and young adults with cancer enrolled in expanded access programs of promising therapies.
TAPUR™ Study
xCures’ treatment options include, where applicable, therapies on the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. TAPUR is a clinical trial for patients with advanced cancer who have not responded to standard treatment or are without available standard treatment options and who have genomic alterations in their tumors that can be targeted with a commercially available anticancer drug.